Trial Profile
Efficacy of ramosetron and palonosetron on patient-controlled analgesia related postoperative nausea and vomiting in gynecological laparoscopic surgery -randomised controlled trial-
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary) ; Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 08 Nov 2011 New trial record